FDA Panel Recommends Emergency Use Authorization of Pfizer COVID Vaccine
Updated: Dec 12, 2020
On Thursday, the FDA's advisory committee recommended that the agency grant emergency use authorization of Pfizer and BioNTech's Covid-19 vaccine.
Now the advisory committee for the Center for Disease Control must also vote on whether to use the Pfizer vaccine. The committee is expected to vote on Sunday.
If the CDC committee supports the emergency use of the Pfizer vaccine as well, vaccines could start rolling out to citizens as soon as 24-48 hours afterwards.
Photo Source: fda.gov